Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-16
DOI
10.3389/fgene.2022.905238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis
- (2022) Yang Li et al. BMC CANCER
- Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
- (2022) Zaoqu Liu et al. Nature Communications
- Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
- (2022) Zaoqu Liu et al. Frontiers in Immunology
- Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer
- (2022) Yue Wang et al. Frontiers in Oncology
- Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis
- (2022) Cheng Li et al. Frontiers in Cell and Developmental Biology
- Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells
- (2021) Lavanya H Palavalli Parsons et al. eLife
- The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia
- (2021) Caixia Han et al. Journal of Translational Medicine
- SIRT1 and gynecological malignancies (Review)
- (2021) Jiayu Chen et al. ONCOLOGY REPORTS
- CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis
- (2021) Wenrui Ye et al. Frontiers in Oncology
- Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy
- (2021) Giorgio Valabrega et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
- (2021) Adrienn Sipos et al. MOLECULAR MEDICINE
- Advances in NAD-Lowering Agents for Cancer Treatment
- (2021) Moustafa S. Ghanem et al. Nutrients
- Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
- (2021) Zaoqu Liu et al. Cancer Cell International
- Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers
- (2021) Sridevi Challa et al. CELL
- NAD + homeostasis in human health and disease
- (2021) Rubén Zapata‐Pérez et al. EMBO Molecular Medicine
- Ovarian Cancer Immunotherapy and Personalized Medicine
- (2021) Susan Morand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated Analysis of the Expression Characteristics, Prognostic Value, and Immune Characteristics of PPARG in Breast Cancer
- (2021) Jianbin Wu et al. Frontiers in Genetics
- Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining
- (2021) Lili Fan et al. Frontiers in Molecular Biosciences
- Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer
- (2021) JianBin Wu et al. Frontiers in Immunology
- Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
- (2021) Zaoqu Liu et al. EBioMedicine
- Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
- (2021) Zirui Zhao et al. Journal of Oncology
- Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma
- (2021) Gaoming Wang et al. Frontiers in Oncology
- An Analysis Regarding the Prognostic Significance of MAVS and Its Underlying Biological Mechanism in Ovarian Cancer
- (2021) Lifeng Chen et al. Frontiers in Cell and Developmental Biology
- NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview
- (2020) Alvinsyah Adhityo Pramono et al. Biomolecules
- Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets
- (2020) Meijing Wu et al. PeerJ
- TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
- (2020) Silvia R. Vitale et al. Biomolecules
- Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
- (2020) Chang Yang et al. Frontiers in Immunology
- Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
- (2020) Hao Sun et al. EBioMedicine
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer
- (2019) Xiao-qin Li et al. Frontiers in Oncology
- An EMT‐related gene signature for the prognosis of human bladder cancer
- (2019) Rui Cao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer
- (2019) Timothy Nacarelli et al. CANCER RESEARCH
- Regulation of Cancer and Cancer-Related Genes via NAD+
- (2018) Tanveer Sharif et al. ANTIOXIDANTS & REDOX SIGNALING
- Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
- (2018) Luis Rajman et al. Cell Metabolism
- Ovarian Cancer
- (2018) Ursula A. Matulonis HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- COSMIC-3D provides structural perspectives on cancer genetics for drug discovery
- (2018) Harry C. Jubb et al. NATURE GENETICS
- NAD+ : A key metabolic regulator with great therapeutic potential
- (2017) G. Sultani et al. JOURNAL OF NEUROENDOCRINOLOGY
- Ovarian Cancer: A Heterogeneous Disease
- (2017) Myriam Kossaï et al. PATHOBIOLOGY
- Ovarian cancer stem cells more questions than answers
- (2017) Petronella Beatrix Ottevanger SEMINARS IN CANCER BIOLOGY
- Ovarian cancer in the older woman
- (2016) William P. Tew Journal of Geriatric Oncology
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
- (2014) Paul Geeleher et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started